Merck & Co., Inc. (MRK)'s (JOBS) Gardasil Has Higher Rates Of Fainting, Clots According to Study  
8/19/2009 7:07:11 AM

Bookmark and Share

Recipients of Merck & Co.'s Gardasil cervical-cancer vaccine had higher rates of fainting and blood clots than those receiving other vaccines, but it doesn't appear to raise the risk of certain severe adverse events, according to a new safety analysis.